What kind of medicine is midostaurin and how much does it cost per box?

Midostaurin, also known as Midostaurin in English, is an oral multi-kinase inhibitor that specifically inhibits tyrosine kinases. This drug has been shown to inhibit multiple kinases in in vitro biochemical or cellular assays, including wild-type FLT3, FLT3 mutant kinase, KIT, and multiple other kinases. Midostaurin can inhibit the activity of these kinases and interfere with the signal transduction of tumor cells, thereby inhibiting the proliferation of tumor cells.

In clinical applications, midostaurin is mainly used to treat specific types of leukemia, such as FLT3 mutation-positive acute myeloid leukemia, and systemic mastocytosis. The drug can significantly extend patients' survival and improve their quality of life. However, some adverse reactions may occur during use, such as nausea, vomiting, headache, musculoskeletal pain, etc., which require close monitoring and timely adjustment of the treatment plan.

In addition, there are some special matters that need to be paid attention to during the use of midostaurin. For example, patients who are allergic to the drug should not use it; pregnant or breastfeeding women should avoid using the drug because it may cause harm to the fetus or newborn; at the same time, pulmonary toxicity is a potential risk of midostaurin, so patients who develop symptoms of interstitial lung disease and pneumonia should stop taking the drug immediately.

Midostaurin is currently not available in China, and patients cannot purchase it directly through domestic hospitals or pharmacies. This original drug is produced by Novartis Pharmaceuticals in Switzerland. The specification is 25mg*112 tablets. The market price in different countries is different: about 120,000 yuan in the European market, about 80,000 yuan in the Turkish market, and only about 17,000 yuan in India. It is worth mentioning that India also has a copy of midostaurin produced by BDR Company, which is more affordable, with a box costing about 9,000 yuan. If the patient has any questions about Midostaurin, the patient is asked to consult an overseas medical consultant.

Overall, midostaurin is an important anti-tumor drug and provides a new treatment option for leukemia patients. During use, it is necessary to strictly abide by medical instructions, pay attention to monitoring adverse reactions, and adjust treatment plans in a timely manner to ensure patient safety.